• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Derm In The News: September 10-16


Keep up with the latest headlines in dermatology from the past week, including advances in diversifying the specialty, artificial skin and its role in eczema research, and more.

AP News: Patients need doctors who look like them. Can medicine diversify without affirmative action?

In dermatology, 3% of doctors are Black, and in medicine, 6% of doctors are Black, despite Black Americans representing 13% of the US population. Experts in dermatology, race, and medicine discuss the importance of striving for better patient outcomes and efforts to diversify the field and education.

9News: New trials for pill to treat skin pigment condition Vitiligo

Researchers in Melbourne, Australia, are currently recruiting patients with vitiligo for a phase 3 trial evaluating the safety and efficacy of an oral pill containing ritlecitinib in patients with vitiligo.

Innovation Map: Baylor Medicine opens inclusive Skin of Color Clinic in Houston

Baylor Medicine Dermatology has launched the Skin of Color Clinic, located in the Jamail Specialty Care Center, to cater to the unique dermatological needs of patients from diverse ethnic backgrounds. Led by Oyetewa Oyerinde, MD, the clinic aims to provide culturally sensitive and competent care for patients with different skin types, addressing issues such as pigmentation concerns, scarring, hair loss, and more.

SBS News: Researchers in Australia discover a new treatment for acne

Researchers in Australia have repurposed an antibiotic called narasin, typically used in the livestock industry, to create a new treatment for acne. Encasing narasin in ultrafine particles and applying it as a gel to acne sites in the laboratory, they found it could effectively inhibit acne bacteria growth. The researchers believe this topical formulation may offer a safer and more targeted alternative to oral antibiotics commonly used to treat acne, which can have negative side effects and contribute to antibiotic resistance. Clinical tests are planned for the next stage of the study.

Post Bulletin: Mayo Clinic dermatology lab makes 3D bioprinted skin for eczema research

Mayo Clinic dermatology lab researchers have developed a 3D bioprinting technique using bioinks, ultimately creating tissue-like structures resembling human skin. This technology offers a highly realistic and human-equivalent model for studying inflammatory skin conditions such as atopic dermatitis, surpassing the accuracy of animal models.

Have you seen any dermatology headlines this week that we may have missed? Share with us by emailing our team at DTEditor@mmhgroup.com.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.